Last reviewed · How we verify
HCW9302, an IL-2 fusion protein — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
HCW9302, an IL-2 fusion protein (HCW9302, an IL-2 fusion protein) — HCW Biologics.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| HCW9302, an IL-2 fusion protein TARGET | HCW9302, an IL-2 fusion protein | HCW Biologics | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- HCW9302, an IL-2 fusion protein CI watch — RSS
- HCW9302, an IL-2 fusion protein CI watch — Atom
- HCW9302, an IL-2 fusion protein CI watch — JSON
- HCW9302, an IL-2 fusion protein alone — RSS
Cite this brief
Drug Landscape (2026). HCW9302, an IL-2 fusion protein — Competitive Intelligence Brief. https://druglandscape.com/ci/hcw9302-an-il-2-fusion-protein. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab